Get the Stockscreener App
3.31
3.44%
0.11
After Hours:
3.24
-0.07
-2.11%
Arbutus Biopharma Corp Stock (ABUS) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues |
28.58%
1.532
|
2.145 | 4.658 | 4.651 | 6.687 |
Operating Expenses
|
8.72%
20.89
|
22.89 | 26.22 | 23.04 | 24.10 |
| Interest Income/Expense |
0.00%
0.044
|
0.044 | 0.046 | 0.171 | 0.198 |
| Benefits Costs and Expenses |
100.00%
-
|
-69.53 | 24.76 | 21.75 | 23.03 |
| Costs And Expenses |
21.77%
20.89
|
26.71 | 24.76 | 21.75 | 23.03 |
| Operating Income/Loss |
6.67%
-19.36
|
-20.75 | -21.56 | -18.39 | -17.41 |
| Nonoperating Income/Loss |
3.69%
1.488
|
1.435 | 1.454 | 1.291 | 1.074 |
| Income/Loss From Continuing Operations Before Tax |
97.86%
1.532
|
71.68 | -20.10 | -17.09 | -16.34 |
| Income/Loss From Continuing Operations After Tax |
7.44%
-17.88
|
-19.31 | -20.10 | -17.09 | -16.34 |
|
Net Income/Loss
|
7.44%
-17.88
|
-19.31 | -20.10 | -17.09 | -16.34 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
19,968%
175.63
|
0.8751 | 167.51 | 166.06 | 161.64 |
| Diluted Average Shares |
19,968%
175.63
|
0.8751 | 167.51 | 166.06 | 161.64 |
| Basic Earnings Per Share |
16.67%
-0.10
|
-0.12 | -0.12 | -0.10 | -0.10 |
| Diluted Earnings Per Share |
16.67%
-0.10
|
-0.12 | -0.12 | -0.10 | -0.10 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):